Biotech Division of Greenland Mines Announces Australian Patent Grant for Klotho Gene Therapy Technology for Treatment of Neuromuscular Diseases
NEW YORK, July 10, 2026 (GLOBE NEWSWIRE) — via IBN — Greenland Mines Ltd (Nasdaq: GRML) (“Greenland Mines” or the “Company”) today announced that IP Australia has granted Australian Patent No…
Read the full articleYou might also wanna read
Unapproved klotho gene therapy for longevity to be sold overseas to bypass FDA regulations
A gene therapy that instructs cells to produce more of an anti-ageing protein called klotho is about to be offered by a US company at overse
newscientist.com·17d agoPrime wins patent fight with Beam to continue work on AATD gene editing therapy
Prime Medicine has come out ahead in its patent dispute with fellow gene-editing biotech Beam Therapeutics, after a panel of adjudicators ru
How Taxpayer-Funded Research Led to a $2 Million Gene Therapy: The Zolgensma Story
Taxpayers and charities helped develop Zolgensma. Then it debuted at a record price, ushering in a new class of wildly expensive drugs. Its
propublica.org·3d ago
CRML, UUUU, USAR, ALOY, GLND: Greenland’s Rare-Earth Trade Draws Investors As Trump Revives Arctic Ambitions
Trump's renewed call for U.S. control of Greenland boosted shares of rare earth companies as investors focused on the island's mineral resou
B2Gold’s new CEO gets his Goose test
Mike Cinnamond faces a key test ramping up Nunavut’s Goose gold mine to revive million-ounce output and prove growth discipline.
Nexus Uranium Aktie: 13 Prozent auf Australien-Indien-Deal
Nexus Uranium erlebt eine scharfe Kehrtwende. Die Aktie des Explorationsunternehmens schoss am Donnerstag um über 13 Prozent auf 0,40 Euro n
Comments
Sign in to join the conversation.
No comments yet. Be the first.